Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
City of Hope Medical Center
City of Hope Medical Center
Emory University
University of Washington
City of Hope Medical Center
University of Washington
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
University of Washington
Beidahuang Industry Group General Hospital
University of Michigan Rogel Cancer Center
Northwestern University
University of Colorado, Denver
University of Arizona
Massachusetts General Hospital
University of Washington
Mayo Clinic
Abramson Cancer Center at Penn Medicine
University Hospital, Grenoble
Barbara Ann Karmanos Cancer Institute
Centre Georges Francois Leclerc
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Samsung Medical Center
Centre Hospitalier Universitaire de Saint Etienne
Vanderbilt-Ingram Cancer Center